(Q36557840)
Statements
2 references
Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness? (English)
L Bourke
P Kirkbride
A J Rosario
29 November 2012
4 references
3 April 2019
17 November 2019
15 October 2020
1 reference
1 reference
1 reference
1 reference